Objective Given the reported increased rates of physical morbidity and higher mortality rates
among people with severe mental illness (SMI)(schizophrenia and severe mood disorders) …

Introduction: Most medical diagnoses present somewhat differently in men and women,
more so at specific periods of life. Treatment effects may also differ. This is true for …

This review indicates that patients with schizophrenia are at increased risk of dying of cancer
and of several specific types of cancer. This increased mortality can be reduced if the price …

Research regarding the incidence of cancer among people with psychotic disorders relative
to the general population is equivocal, although the evidence suggests that they have more …

Background Breast cancer is more common in female patients with schizophrenia than in
the general population. It is not known whether treatment with prolactin-increasing …

Over a century ago, the phenothiazine dye, methylene blue, was discovered to have both
antipsychotic and anti-cancer effects. In the 20th-century, the first phenothiazine …

The paucity of data regarding patients with Serious Mental Illness (SMI) and cancer is
alarming given the fact that people with SMI, especially schizophrenia, bipolar disorders and …

Background Observational studies analyzing the risk of prostate cancer in schizophrenia
patients have generated mixed results. We performed a meta-analysis and a Mendelian …

Background Previous observational studies have reported inconsistent findings regarding
the incidence of cancer in patients with schizophrenia compared to the general population …

Background Neuropsychiatric disorders, such as schizophrenia (SZ) and autism spectrum
disorder (ASD), are common, multi-factorial and multi-symptomatic disorders. Ample …